ProfileGDS4718 / 222932_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 16% 25% 11% 20% 19% 21% 25% 18% 13% 26% 24% 16% 26% 22% 14% 24% 23% 24% 21% 18% 19% 19% 24% 23% 16% 26% 22% 4% 21% 16% 18% 13% 21% 26% 24% 18% 20% 16% 18% 15% 24% 20% 12% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.016316
GSM549102patient 115, normal, homogenized [OPG study]4.3537225
GSM549104patient 119, normal, homogenized [OPG study]3.7894711
GSM549108patient 138, normal, homogenized [OPG study]4.1645220
GSM549119patient 077, normal, homogenized [OPG study]4.1167319
GSM549133patient 032, cancer, homogenized [OPG study]4.1309521
GSM549139patient 042, cancer, homogenized [OPG study]4.3129325
GSM549099patient 107, normal, homogenized [OPG study]4.0759418
GSM549109patient 139, normal, homogenized [OPG study]3.9341413
GSM549110patient 046, normal, homogenized [OPG study]4.3691926
GSM549114patient 063, normal, homogenized [OPG study]4.2651124
GSM549122patient 082, normal, homogenized [OPG study]3.9972216
GSM549134patient 033, cancer, homogenized [OPG study]4.3818426
GSM549136patient 036, cancer, homogenized [OPG study]4.1680622
GSM549140patient 044, cancer, homogenized [OPG study]3.8900414
GSM549111patient 047, normal, homogenized [OPG study]4.2680524
GSM549113patient 057, normal, homogenized [OPG study]4.1877223
GSM549132patient 031, cancer, homogenized [OPG study]4.2720424
GSM549137patient 038, cancer, homogenized [OPG study]4.1693921
GSM549142patient 047, cancer, homogenized [OPG study]4.1701518
GSM549100patient 110, normal, homogenized [OPG study]4.1317919
GSM549107patient 135, normal, homogenized [OPG study]4.0897519
GSM549115patient 068, normal, homogenized [OPG study]4.2559624
GSM549116patient 072, normal, homogenized [OPG study]4.2559623
GSM549120patient 078, normal, homogenized [OPG study]3.9902616
GSM549131patient 030, cancer, homogenized [OPG study]4.318426
GSM549118patient 074, normal, homogenized [OPG study]4.2251122
GSM549129patient 027, cancer, homogenized [OPG study]3.558094
GSM549123patient 088, normal, homogenized [OPG study]4.1832621
GSM549124patient 006, cancer, homogenized [OPG study]4.0190416
GSM549126patient 015, cancer, homogenized [OPG study]4.0475818
GSM549128patient 025, cancer, homogenized [OPG study]3.8655313
GSM549103patient 117, normal, homogenized [OPG study]4.233321
GSM549117patient 073, normal, homogenized [OPG study]4.3686426
GSM549138patient 041, cancer, homogenized [OPG study]4.288924
GSM549141patient 045, cancer, homogenized [OPG study]4.0167618
GSM549130patient 028, cancer, homogenized [OPG study]4.1724720
GSM549101patient 111, normal, homogenized [OPG study]3.9818616
GSM549105patient 128, normal, homogenized [OPG study]4.0964318
GSM549106patient 134, normal, homogenized [OPG study]3.9012915
GSM549112patient 048, normal, homogenized [OPG study]4.289624
GSM549125patient 011, cancer, homogenized [OPG study]4.1492320
GSM549127patient 024, cancer, homogenized [OPG study]3.8429312
GSM549135patient 035, cancer, homogenized [OPG study]3.8936714